Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluation

Bayrak, SONGÜL; Ozturk, Cansu; Gerni, Serpil; Atmaca, Ufuk; Kilinc, Namik

doi:10.1080/17568919.2026.2688861

Makale Tam Makale Uluslararası 2026

Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluation

SONGÜL Bayrak, Cansu Ozturk, Serpil Gerni, Ufuk Atmaca, Namik Kilinc

Future Medicinal Chemistry Cilt 18 · Sayı 15 · ss. 1963–1978 · 01.01.2026

DOI ile aç

Anahtar kelimeler

ANTIMICROBIAL ACTIVITY ANTIOXIDANT ACTIVITY Molecular docking CARBONIC-ANHYDRASE INHIBITORS Molecular dynamics Butenolide derivatives

Atıf için künye

Bayrak, S., Ozturk, C., Gerni, S., Atmaca, U., & Kilinc, N. (2026). Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluation. Future Medicinal Chemistry, 18(15), 1963–1978. https://doi.org/10.1080/17568919.2026.2688861

BibTeX

@article{bayrak2026-72496,
  author = {Bayrak, SONGÜL and Ozturk, Cansu and Gerni, Serpil and Atmaca, Ufuk and Kilinc, Namik},
  title = {Butenolide-based human carbonic anhydrase (hCA) I/II inhibitors: integrated computational and biological evaluation},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  volume = {18},
  number = {15},
  pages = {1963--1978},
  issn = {1756-8919},
  doi = {10.1080/17568919.2026.2688861},
  url = {https://akademik.atauni.edu.tr/yayinlar/72496-butenolide-based-human-carbonic-anhydrase-hca-iii-inhibitors-integrated}
}